What was Roland R. Griffiths diagnosis?

The Johns Hopkins University School of Medicine’s Departments of Psychiatry and Neurosciences are home to Professor Roland Griffiths, Ph.D. The behavioral and subjective effects of mood-altering medications have been the main areas of his research in both clinical and preclinical laboratories.

He has authored more than 400 journal papers and book chapters, received funds from the National Institute on Health to support a substantial portion of his research, and mentored more than 50 postdoctoral research fellows.

He has served as a consultant to the National Institutes of Health, various pharmaceutical firms working on the creation of novel psychotropic medications, and the World Health Organization’s Expert Advisory Panel on Drug Dependence. He has done a lot of research on coffee, sedative-hypnotics, and other mood-altering substances.

What was Roland R. Griffiths diagnosis?

In November 2021, Dr. Griffiths received a Stage 4 colon cancer diagnosis, a revelation he came to accept, as he explained to David Marchese of The New York Times Magazine. He persuaded Johns Hopkins to create an endowed professorship in his honor for study into how psychedelics affect wellbeing and spirituality. He was finishing a report describing a study he had done in which clergy from many faiths were given high doses of psilocybin to examine how it would alter their life and work at the time of his death.